BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

680 related articles for article (PubMed ID: 33216042)

  • 1. Statistically Defined Parkinson's Disease Executive and Memory Cognitive Phenotypes: Demographic, Behavioral, and Structural Neuroimaging Comparisons.
    Crowley SJ; Banan G; Amin M; Tanner JJ; Hizel L; Nguyen P; Brumback B; Rodriguez K; McFarland N; Bowers D; Ding M; Mareci TA; Price CC
    J Parkinsons Dis; 2021; 11(1):283-297. PubMed ID: 33216042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gray and White Matter Contributions to Cognitive Frontostriatal Deficits in Non-Demented Parkinson's Disease.
    Price CC; Tanner J; Nguyen PT; Schwab NA; Mitchell S; Slonena E; Brumback B; Okun MS; Mareci TH; Bowers D
    PLoS One; 2016; 11(1):e0147332. PubMed ID: 26784744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal Lobe and Frontal-Subcortical Dissociations in Non-Demented Parkinson's Disease with Verbal Memory Impairment.
    Tanner JJ; Mareci TH; Okun MS; Bowers D; Libon DJ; Price CC
    PLoS One; 2015; 10(7):e0133792. PubMed ID: 26208170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hierarchical cluster analysis of multimodal imaging data identifies brain atrophy and cognitive patterns in Parkinson's disease.
    Inguanzo A; Sala-Llonch R; Segura B; Erostarbe H; Abos A; Campabadal A; Uribe C; Baggio HC; Compta Y; Marti MJ; Valldeoriola F; Bargallo N; Junque C
    Parkinsonism Relat Disord; 2021 Jan; 82():16-23. PubMed ID: 33227683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marked brain asymmetry with intact cognitive functioning in idiopathic Parkinson's disease: a longitudinal analysis.
    Tanner JJ; Levy SA; Schwab NA; Hizel LP; Nguyen PT; Okun MS; Price CC
    Clin Neuropsychol; 2017 Apr; 31(3):654-675. PubMed ID: 27813459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical relevance of amnestic versus non-amnestic mild cognitive impairment subtyping in Parkinson's disease.
    Chung SJ; Park YH; Yun HJ; Kwon H; Yoo HS; Sohn YH; Lee JM; Lee PH
    Eur J Neurol; 2019 May; 26(5):766-773. PubMed ID: 30565368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topologically convergent and divergent morphological gray matter networks in early-stage Parkinson's disease with and without mild cognitive impairment.
    Suo X; Lei D; Li N; Li J; Peng J; Li W; Yang J; Qin K; Kemp GJ; Peng R; Gong Q
    Hum Brain Mapp; 2021 Oct; 42(15):5101-5112. PubMed ID: 34322939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Executive function network's white matter alterations relate to Parkinson's disease motor phenotype.
    Yang Q; Nanivadekar S; Taylor PA; Dou Z; Lungu CI; Horovitz SG
    Neurosci Lett; 2021 Jan; 741():135486. PubMed ID: 33161103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered functional connectivity in the default mode network is associated with cognitive impairment and brain anatomical changes in Parkinson's disease.
    Lucas-Jiménez O; Ojeda N; Peña J; Díez-Cirarda M; Cabrera-Zubizarreta A; Gómez-Esteban JC; Gómez-Beldarrain MÁ; Ibarretxe-Bilbao N
    Parkinsonism Relat Disord; 2016 Dec; 33():58-64. PubMed ID: 27659747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-sectional and longitudinal associations between total and regional white matter hyperintensity volume and cognitive and motor function in Parkinson's disease.
    Pozorski V; Oh JM; Okonkwo O; Krislov S; Barzgari A; Theisen F; Sojkova J; Bendlin BB; Johnson SC; Gallagher CL
    Neuroimage Clin; 2019; 23():101870. PubMed ID: 31150958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gray and white matter imaging: A biomarker for cognitive impairment in early Parkinson's disease?
    Duncan GW; Firbank MJ; Yarnall AJ; Khoo TK; Brooks DJ; Barker RA; Burn DJ; O'Brien JT
    Mov Disord; 2016 Jan; 31(1):103-10. PubMed ID: 26202802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apathy in Mild Parkinson's Disease: Neuropsychological and Neuroimaging Evidence.
    Alzahrani H; Antonini A; Venneri A
    J Parkinsons Dis; 2016 Oct; 6(4):821-832. PubMed ID: 27567885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced lateral occipital gray matter volume is associated with physical frailty and cognitive impairment in Parkinson's disease.
    Chen YS; Chen HL; Lu CH; Chen MH; Chou KH; Tsai NW; Yu CC; Chiang PL; Lin WC
    Eur Radiol; 2019 May; 29(5):2659-2668. PubMed ID: 30523452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging changes associated with cognitive abnormalities in Parkinson's disease.
    Koshimori Y; Segura B; Christopher L; Lobaugh N; Duff-Canning S; Mizrahi R; Hamani C; Lang AE; Aminian K; Houle S; Strafella AP
    Brain Struct Funct; 2015 Jul; 220(4):2249-61. PubMed ID: 24816399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression of subcortical atrophy in mild Parkinson's disease and its impact on cognition.
    Foo H; Mak E; Yong TT; Wen MC; Chander RJ; Au WL; Sitoh YY; Tan LC; Kandiah N
    Eur J Neurol; 2017 Feb; 24(2):341-348. PubMed ID: 27943468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translating ENIGMA schizophrenia findings using the regional vulnerability index: Association with cognition, symptoms, and disease trajectory.
    Kochunov P; Fan F; Ryan MC; Hatch KS; Tan S; Jahanshad N; Thompson PM; van Erp TGM; Turner JA; Chen S; Du X; Adhikari B; Bruce H; Hare S; Goldwaser E; Kvarta M; Huang J; Tong J; Cui Y; Cao B; Tan Y; Hong LE
    Hum Brain Mapp; 2022 Jan; 43(1):566-575. PubMed ID: 32463560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cortical gray and subcortical white matter associations in Parkinson's disease.
    Sterling NW; Du G; Lewis MM; Swavely S; Kong L; Styner M; Huang X
    Neurobiol Aging; 2017 Jan; 49():100-108. PubMed ID: 27776262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of diffusion kurtosis changes in Parkinson's disease subtypes.
    Sejnoha Minsterova A; Klobusiakova P; Pies A; Galaz Z; Mekyska J; Novakova L; Nemcova Elfmarkova N; Rektorova I
    Parkinsonism Relat Disord; 2020 Dec; 81():96-102. PubMed ID: 33120076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology.
    Gao Y; Nie K; Huang B; Mei M; Guo M; Xie S; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
    Neurosci Lett; 2017 Sep; 658():121-132. PubMed ID: 28823894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain MRI morphometric analysis in Parkinson's disease patients with sleep disturbances.
    Radziunas A; Deltuva VP; Tamasauskas A; Gleizniene R; Pranckeviciene A; Petrikonis K; Bunevicius A
    BMC Neurol; 2018 Jun; 18(1):88. PubMed ID: 29925331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.